Wei Wen

488 total citations
25 papers, 350 citations indexed

About

Wei Wen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wei Wen has authored 25 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Wei Wen's work include Liver physiology and pathology (3 papers), Gastric Cancer Management and Outcomes (3 papers) and MicroRNA in disease regulation (2 papers). Wei Wen is often cited by papers focused on Liver physiology and pathology (3 papers), Gastric Cancer Management and Outcomes (3 papers) and MicroRNA in disease regulation (2 papers). Wei Wen collaborates with scholars based in China, United States and Philippines. Wei Wen's co-authors include Ying Zhu, Xiaoli Zhang, Peiqing Zhao, Miao Xu, Ye Yuan, Wei Hu, Rui‐Ping Xiao, Kui Liu, Xiuqin Zhang and Yi Zhao and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Wei Wen

20 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wen China 11 179 127 90 60 48 25 350
Xianli He China 10 242 1.4× 143 1.1× 142 1.6× 52 0.9× 96 2.0× 19 469
Marko Kornmann Germany 10 179 1.0× 78 0.6× 178 2.0× 70 1.2× 63 1.3× 26 375
Deyang Li China 12 204 1.1× 110 0.9× 52 0.6× 26 0.4× 35 0.7× 23 310
Haiyan Dai China 11 232 1.3× 130 1.0× 75 0.8× 34 0.6× 28 0.6× 22 374
Anal Desai United States 5 268 1.5× 74 0.6× 53 0.6× 60 1.0× 40 0.8× 5 412
Dan‐Ming Wei China 11 271 1.5× 182 1.4× 59 0.7× 34 0.6× 74 1.5× 26 422
Zefeng Xuan China 11 211 1.2× 84 0.7× 67 0.7× 41 0.7× 49 1.0× 18 296
King Xin Koh Singapore 7 242 1.4× 185 1.5× 100 1.1× 90 1.5× 65 1.4× 8 440
Longci Sun China 9 197 1.1× 127 1.0× 53 0.6× 29 0.5× 71 1.5× 17 327
Jianxu Chen China 11 178 1.0× 158 1.2× 89 1.0× 55 0.9× 51 1.1× 15 384

Countries citing papers authored by Wei Wen

Since Specialization
Citations

This map shows the geographic impact of Wei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wen more than expected).

Fields of papers citing papers by Wei Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wen. The network helps show where Wei Wen may publish in the future.

Co-authorship network of co-authors of Wei Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wen. A scholar is included among the top collaborators of Wei Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wen. Wei Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Wen, Wei, et al.. (2024). LL-37 improves sepsis-induced acute lung injury by suppressing pyroptosis in alveolar epithelial cells. International Immunopharmacology. 129. 111580–111580. 13 indexed citations
5.
6.
Yu, Mengjie, Wei Wen, Yue Wang, et al.. (2024). Plasma metabolomics reveals risk factors for lung adenocarcinoma. Frontiers in Oncology. 14. 1277206–1277206. 3 indexed citations
7.
Zhang, Yusong, et al.. (2023). Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. Frontiers in Immunology. 14. 1227143–1227143. 3 indexed citations
8.
Wen, Wei, et al.. (2022). Arnicolide D Inhibits Oxidative Stress-induced Breast Cancer Cell Growth andInvasion through Apoptosis, Ferroptosis, and Parthanatos. Anti-Cancer Agents in Medicinal Chemistry. 24(11). 836–844. 7 indexed citations
9.
Wang, Jue, Wen Zheng, Shuquan Zheng, et al.. (2022). Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys. Molecular Therapy — Nucleic Acids. 31. 68–77. 11 indexed citations
10.
Yu, Mengjie, Wei Wen, Xin Yi, et al.. (2022). Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 12. 829350–829350. 9 indexed citations
11.
Wen, Wei, et al.. (2022). In Vivo Visualization of Gastric, Colon, and Pancreatic Adenocarcinomas Using a Novel Cathepsin-Activated Fluorescent Probe VGT-309. Journal of the American College of Surgeons. 235(5). S246–S246. 1 indexed citations
12.
Yang, Yan, Hu Xu, Jiandong Wang, et al.. (2019). Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus. Bioscience Reports. 39(7). 19 indexed citations
13.
Hu, Wei, Yi Zhao, Wei Wen, et al.. (2019). Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a. Cancer Biomarkers. 24(3). 269–277. 42 indexed citations
14.
Zeng, Fanxin, Xiao Chen, Wei Wen, et al.. (2018). RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca2+ Uptake and Promotes Colorectal Oncogenesis. Cancer Research. 78(11). 2876–2885. 70 indexed citations
15.
Yu, Yang, Chang Liu, Junxia Zhang, et al.. (2017). Rtfc (4931414P19Rik) Regulates in vitro Thyroid Differentiation and in vivo Thyroid Function. Scientific Reports. 7(1). 43396–43396. 3 indexed citations
16.
Wang, Feng, et al.. (2017). Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway. Molecular and Cellular Biochemistry. 429(1-2). 113–122. 22 indexed citations
17.
Wen, Wei, Ge Liu, Ke Jin, & Xiang Hu. (2016). TGF-β1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells. Oncology Reports. 37(1). 115–122. 8 indexed citations
18.
Liu, Chang, Yang Yu, Guangliang Yin, et al.. (2016). C14orf93 ( RTFC ) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer. Biochemical and Biophysical Research Communications. 482(4). 590–596. 17 indexed citations
19.
Zhang, Xiaolong, Wei Wen, Wenxiu Yao, et al.. (2011). Clinical management of gastric cancer: results of a multicentre survey. BMC Cancer. 11(1). 369–369. 3 indexed citations
20.
Liu, Ge, Quan Bao, Wei Sun, et al.. (2010). The Baseline Ratio of Neutrophils to Lymphocytes is Associated with Patient Prognosis in Rectal Carcinoma. Journal of Gastrointestinal Cancer. 41(2). 116–120. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianli He Breakdown of academic impact, for papers by Marko Kornmann Breakdown of academic impact, for papers by Deyang Li Breakdown of academic impact, for papers by Haiyan Dai Breakdown of academic impact, for papers by Anal Desai Breakdown of academic impact, for papers by Dan‐Ming Wei Breakdown of academic impact, for papers by Zefeng Xuan Breakdown of academic impact, for papers by King Xin Koh Breakdown of academic impact, for papers by Longci Sun Breakdown of academic impact, for papers by Jianxu Chen
Rankless by CCL
2026